SCIE.05.41
REGULATION OF ALTERNATIVE SPLICING OF CA2+ CHANNELS BY CRISPR/CAS9-MEDIATED GENOME EDITING AS AN ALL-PURPOSE GENETIC THERAPY FOR LOSS-OF-FUNCTION CACNA1A MUTATIONS
SCIE.11.34
GLUT1 DEFICIENCY: NEW THERAPEUTIC STRATEGIES TO INCREASE GLUCOSE TRANSPORT ACROSS THE BLOOD BRAIN BARRIER (BBB)